KEGG   DRUG: Epoetin betaHelp
Entry
D03232                      Drug                                   

Name
Epoetin beta (USAN/INN);
Epoetin beta (genetical recombination) (JP17);
Marogen (TN)
Formula
C809H1301N229O240S5
Exact mass
18224.5242
Mol weight
18235.7015
Remark
Therapeutic category: 3999
ATC code: B03XA01
Chemical structure group: DG00177
Product (DG00177): D03231<JP/US> D03232<JP>
Efficacy
Anti-anemic, Hematinic, Erythropoietin receptor agonist
Target
EPOR [HSA:2057] [KO:K05079]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  JAK-STAT signaling pathway
hsa04640  Hematopoietic cell lineage
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B03 ANTIANEMIC PREPARATIONS
   B03X OTHER ANTIANEMIC PREPARATIONS
    B03XA Other antianemic preparations
     B03XA01 Erythropoietin
      D03232  Epoetin beta (USAN/INN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
 3  Agents affecting metabolism
  39  Other agents affecting metabolism
   399  Miscellaneous
    3999  Others
     D03232  Epoetin beta (USAN/INN); Epoetin beta (genetical recombination) (JP17)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   CSF and other factor receptors
    EPOR
     D03232  Epoetin beta (USAN/INN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D03232  Epoetin beta (genetical recombination)
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D03232
BRITE hierarchy
Other DBs
CAS: 122312-54-3
PubChem: 17397385
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system